Peginterferon(PEG-IFN) alfa-2a in chronic hepatitis B patients without nucleos(t)ide analogues (NA) treatment
Not Applicable
- Conditions
- Patients infected with hepatitis B virus
- Registration Number
- JPRN-UMIN000007946
- Lead Sponsor
- Chiba University, Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1) Pregnancy 2) Severe liver diseases 3) Cirrhosis or hepatic failure such as chronic liver diseases, e.g. autoimmune hepatitis and alcoholic hepatitis 4) Severe other diseases 5) History of pneumonitis 6) Past-history of hypersensitivity against interferon or peginterferon, etc. 7) Severe mental disorders 8) Abnormal hematological exams 9) Past-history of hypersensitivity against vaccination, etc. 10) Under treatment of TJ-9 11) Doctor judged patient as inappropriate person in this trial
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method HBV DNA and ALT levels at 24 week after stopping the treatment
- Secondary Outcome Measures
Name Time Method